文献速递先天性心脏病外科

心室功能障碍与房室瓣反流对Fontan术前减员的影响

Impact of Ventricular Dysfunction and Atrioventricular Valve Regurgitation on Pre-Fontan Attrition.
PubMed 文献 · Ann Thorac Surg · 2023-07-08

该单中心回顾性队列研究纳入2008至2020年接受Norwood姑息手术并随后行上腔静脉肺动脉连接的婴儿,探讨至少中度心室功能障碍(VD)和房室瓣反流(AVVR)对Fontan术前减员的影响。结果显示,孤立VD与减员无关,但孤立AVVR和VD合并AVVR均与减员 odds 升高相关,仅VD合并AVVR者无移植生存率显著更差。

要点

  • Fontan术前减员发生率为12.7%(34/267)。
  • 孤立AVVR患者减员 odds 为无VD或AVVR者的5.4倍(95%CI 1.8-16.2)。
  • VD合并AVVR患者减员 odds 为无VD或AVVR者的20.1倍(95%CI 7.7-52.8)。

核心结论

  • VD和AVVR的叠加效应是Fontan术前减员的重要促成因素。
  • 未来研究探讨可减轻AVVR程度的疗法可能有助于提高Fontan完成率和长期结局。

研究设计与样本

  • 单中心回顾性队列研究,纳入2008至2020年接受Norwood姑息手术并随后行上腔静脉肺动脉连接的婴儿,共267例。
  • Fontan术前减员定义为死亡、Fontan完成前列入心脏移植名单或不适合Fontan完成;次要结局为无移植生存率。

主要发现

  • 267例中34例(12.7%)发生Fontan术前减员。
  • 孤立VD与减员无关。
  • 与无VD或AVVR者相比,孤立AVVR者减员 odds 为5.4倍(OR 5.4,95%CI 1.8-16.2),VD合并AVVR者减员 odds 为20.1倍(OR 20.1,95%CI 7.7-52.8)。
  • 仅VD合并AVVR者无移植生存率显著差于无VD或AVVR者(HR 7.7,95%CI 2.8-21.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a significant incidence of pre-Fontan attrition-defined as failure to undergo Fontan completion-after superior cavopulmonary connection. This study investigated the impact of at least moderate ventricular dysfunction (VD) and atrioventricular valve regurgitation (AVVR) on pre-Fontan attrition. METHODS: This single-center retrospective cohort study included all infants who underwent Norwood palliation from 2008 to 2020 and subsequently underwent superior cavopulmonary connection. Pre-Fontan attrition was defined as death, listing for heart transplantation before Fontan completion, or unsuitability for Fontan completion. The study's secondary outcome was transplant-free survival. RESULTS: Pre-Fontan attrition occurred in 34 of 267 patients (12.7%). Isolated VD was not associated with attrition. However, patients with isolated AVVR had 5 times the odds of attrition (odds ratio, 5.4; 95% CI 1.8-16.2), and patients with both VD and AVVR had 20 times the odds of attrition (odds ratio, 20.1; 95% CI 7.7-52.8) compared with patients without VD or AVVR. Only patients with both VD and AVVR had significantly worse transplant-free survival compared with patients without VD or AVVR (hazard ratio, 7.7; 95% CI 2.8-21.6). CONCLUSIONS: The additive effect of VD and AVVR is a powerful contributor to pre-Fontan attrition. Future research investigating therapies that can mitigate the degree of AVVR may help improve Fontan completion rates and long-term outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Stack KO, Schluger C, Roberts AL, et al. Impact of Ventricular Dysfunction and Atrioventricular Valve Regurgitation on Pre-Fontan Attrition. Ann Thorac Surg. 2023. PMID: 37429514. doi:10.1016/j.athoracsur.2023.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。